단순 헤르페스 제 1형 티미딘 키나제 유전자 이입 간암세포주에서 방사표지 IVDU와 IVFRU의 섭취 평가

In Vitro Uptakes of Radiolabeled IVDU and IVFRU in Herpes Simplex Virus Type-1 Thymidine Kinase (HSV1-tk) Gene Transduced Morris Hepatoma Cell Line

  • 이태섭 (원자력의학원 싸이클로트론응용연구실) ;
  • 최태현 (원자력의학원 싸이클로트론응용연구실) ;
  • 안순혁 (원자력의학원 싸이클로트론응용연구실) ;
  • 우광선 (원자력의학원 싸이클로트론응용연구실) ;
  • 정위섭 (원자력의학원 싸이클로트론응용연구실) ;
  • 권희충 (원자력의학원 분자종양학연구실) ;
  • 오옥두 (연세대학교 보건과학대학 임상병리학과) ;
  • 최창운 (원자력의학원 싸이클로트론응용연구실) ;
  • 임상무 (원자력의학원 싸이클로트론응용연구실)
  • Lee, Tae-Sup (Laboratory of Cyclotron Application, Korea Institute of Radiological and Medical Sciences(KIRAMS)) ;
  • Choi, Tae-Hyun (Laboratory of Cyclotron Application, Korea Institute of Radiological and Medical Sciences(KIRAMS)) ;
  • Ahn, Soon-Hyuk (Laboratory of Cyclotron Application, Korea Institute of Radiological and Medical Sciences(KIRAMS)) ;
  • Woo, Kwang-Sun (Laboratory of Cyclotron Application, Korea Institute of Radiological and Medical Sciences(KIRAMS)) ;
  • Jeong, Wee-Sup (Laboratory of Cyclotron Application, Korea Institute of Radiological and Medical Sciences(KIRAMS)) ;
  • Kwon, Hee-Chung (Laboratory of Molecular Oncology, Korea Institute of Radiological and Medical Sciences(KIRAMS)) ;
  • Awh, Ok-Doo (Department of Medical Laboratory Science, College of Health Science, Yonsei University) ;
  • Choi, Chang-Woon (Laboratory of Cyclotron Application, Korea Institute of Radiological and Medical Sciences(KIRAMS)) ;
  • Lim, Sang-Moo (Laboratory of Cyclotron Application, Korea Institute of Radiological and Medical Sciences(KIRAMS))
  • 발행 : 2004.02.28

초록

목적: 단순 헤르페스 제 1형 티미딘 키나제(herpes simplex virus type 1 thymidine kinase gene: HSV1-tk)는 GCV와 함께 유전자치료의 한 방법으로서 가장 활발하게 연구되어왔으며, HSV1-tk 효소에 대한 다양한 기질들이 연구되어서 이를 보고 기질로 한 비침습적인 HSV1-tk 유전자 영상시스템에서 가장 널리 사용되고 있다. 본 연구에서는 보고기질로서 방사성 요오드가 표지된 5-iodovinyl-2-deoxyuridine (IVDU) and 5 -iodovinyl-2-fluoro-2-deoxyuridine (IVFRU)를 보고 기질로 하여 HSV1-tk 유전자 영상시스템에서의 유용성을 확인하고자 하였다. 대상 및 방법 HSV1-tk 유전자 영상을 위하여 HSV1-tk 유전자를 레트로 바이러스 벡터를 이용하여 Morris hepatoma 세포주(MCA-tk)에 이입한 세포주를 제조하였으며, HSV1-tk 유전자의 발현을 확인하기 위하여 Northern blotting과 Western Blotting을 시행하였다. 대조세포주인 MCA와 제조된 MCA-tk 세포주에 방사표지 IVDU와 IVFRU를 이용하여 480분까지 세포내 섭취율을 평가하였으며, 또한 MCA-tk 세포주의 백분율을 증가시키면서 이에 따른 IVDU와 IVFRU의 섭취율을 평가함으로서 섭취율과 세포수와의 상관관계를 평가하였다. 결과: MCA-tk 세포주에서 HSV1-tk의 mRNA의 발현과 HSV1-TK 단백질의 발현을 확인하였다. 방사성 요오드 표지 IVDU와 IVFRU 모두는 MCA 세포주에서는 아주 낮은 섭취율을 나타내었으며, MCA-tk 세포주에서는 모두 증가된 섭취를 보였다. IVDU가 480분에서 IVFRU보다 4배 높은 섭취를 나타내었다(p<0.01). 방사표지 IVDU와 IVFRU 모두에서 MCA-tk의 백분율의 증가에 따라서 직선적인 상관관계($R^2>0.96$)를 나타내었다. 결론: 방사성 요오드 표지 IVDU와 IVFRU는 HSV1-tk유전자가 이입된 간암세포주에서 모두 특이적인 높은 섭취율을 나타내고 직선적인 상관관계가 나타나서 두 기질 모두 HSV1-tk유전자 영상시스템에서 보고 기질로서 유용하게 사용될 수 있을것으로 기대된다.

Purpose: The herpes simplex virus type 1 thymidine kinase gene(HSV1-tk) is an attractive candidate as a reporter gene in noninvasive reporter gene monitoring system. The HSV1-tk gene was chosen as a reporter gene, because it has been extensively studied, and there are appropriate reporter probes, substrates of HSV1-tk gene product, to apply for HSV1-tk gene imaging. We used radiolabeled 5-iodovinyl-2'-deoxyuridine (IVDU) and 5-iodovinyl-2'-fluoro-2'-deoxyuridine (IVFRU) as reporter probes for HSV1-tk gene monitoring system. Materials and Methods: We prepared HSV1-tk gene transduced Morris hepatoma cell line using retroviral vector, MOLTEN containing HSV1-tk gene. And we confirmed the HSV1-tk gene expression by Northern blotting and Western blotting. We compared in vitro uptakes of radioiodinated IVDU and IVFRU to monitor HSV1-tk gene expression in Morris hepatoma cell line (MCA) and HSV1-tk gene tranduced MCA (MCA-tk) cells until 480 minutes. We also peformed correlation analysis between percentage of HSV1-tk gene tranduced MCA cell % (MCA-tk%) and uptakes of radiolabeled IVDU or IVFRU. Results: MCA-tk cell expressed HSV1-tk mRNA and HSV1-TK protein. Two compounds showed minimal uptake in MCA, but increased uptake was observed in MCA-tk. IVDU showed 4-fold higher accumulation than IVFRU at 480 min in MCA-tk (p<0.01). Both IVDU and IVFRU uptake were linearly correlated ($R^2>0.96$) with increasing MCA-tk%. Conclusion: The radiolabeld IVDU and IVFRU showed higher specific accumulation in retrovirally HSV1-tk gene transfected Morris hepatoma cell line. Both IVDU and IVFRU could be used as good substrates for evaluation of HSV1-tk gene expression.

키워드

참고문헌

  1. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30 https://doi.org/10.1016/0092-8674(95)90385-2
  2. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994 ;54:4855-4878
  3. Freeman SM, Whartenby KA, Freeman JL, Abboud CN, Marrogi AJ. In situ use of suicide genes for cancer therapy. Semin Oncol 1996;23(1):31-45
  4. Culver KW, Blaese RM. Gene therapy for cancer. Trends Genet 1994;10:174-178 12. Culver KW, Blaese RM. Gene therapy for cancer. Trends Genet 1994;10:174-178
  5. Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci USA 1977;74:5716-5720 https://doi.org/10.1073/pnas.74.12.5716
  6. Smee DF, Martin JC, Verheyden JP, Matthews TR. Anti-herpesvirus activity of the acyclic nucleoside 9 - (1,3-dihydroxy-2-propoxymethyl)guanine. Antimicrob Agents Chemother 1983;23:676-682 https://doi.org/10.1128/AAC.23.5.676
  7. De Clercq E, Descamps J, Balzarini J, Fukui T, Allaudeen HS. Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine. Biochem J 1983;211(2):439-45 https://doi.org/10.1042/bj2110439
  8. Watanabe KA, Reichman U, Hirota K, Lopez C, Fox JJ. Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuran-osylpyrimidine nucleosides. J Med Chem 1979;22:21-24
  9. Balzarini J, Bohman C, De Clercq E. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2- propoxymethyl) guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. J Biol Chem 1993;268:6332-6337
  10. Balzarini J, De Clercq E, Verbruggen A, Ayusawa D, Seno T. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene. Mol Pharmacol 1985;28:581-587
  11. Balzarini L, Morin KW, Kanus EE, Wiebe LI, De Clercq E. Novel (E)-5-(2-iodovinyl)-2-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors. Gene Ther 1995;2:317-322 https://doi.org/10.1016/0893-133X(89)90039-0
  12. Tjuvajev JG, Stockhammer G, Desai R, Uehara H, Watanabe K, Gansbacher B, Blasberg RG. Imaging the expression of transfected genes in vivo. Cancer Res 1995;55:6126-6132
  13. Abrams DN, Lee YW, Mercer JR, KnausEE, Wiebe LI. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models. IX. Radiolabeled 1-(2-fluoro-2-deoxy-$\beta$-D-ribofuranosyl)uracil and 1-(2-chloro-2-deoxy-$\beta$-D- ribofuranosyl) uracil. Br J Radiol 1986;59:263-268.
  14. Choi TH, Ahn SH, Choi CW, Lim SM, Awh OD. Synthesis of substrates for gene monitoring of HSV1-tk system. Korean J Nucl Med 2002;36:102-109
  15. Zinn KR, Chaudhuri TR, Buchsbaum DJ, Mountz JM, Rogers BE. Simultaneous evaluation of dual gene transfer to adherent cells by gamma-ray imaging. Nucl Med Biol 2001;28:135-144 https://doi.org/10.1016/S0969-8051(00)00207-9
  16. de Vries EF, van Waarde A, Harmsen MC, Mulder NH, Vaalburg W, Hospers GA. $[^{11}C]FMAU and[^{18}F]FHPG$ as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections. Nucl Med Biol 2000;27:113-119 https://doi.org/10.1016/S0969-8051(99)00105-5
  17. Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, Finn R, Bornmann W, Thaler H, Conti PS, Blasberg RG.. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 2002;43:1072-1083
  18. Wang HE, Deng WP, Chang PF, Chang CW, Liu RS, Lin WJ, Ting G.. Evaluation and comparison $of^{18}F-FHBG and ^{131}$I-FIAU as gene probes in gene therapy [abstract]. J Nucl Med 2002;43(Suppl):274
  19. Alauddin MM, Shahinian A, Gordon EM, Hall FL, Conti PS. Comparative evaluation of FMAU and acycloguanine derivatives, FHPG and FHBG in MDA-MB-468 breast cancer cells for gene therapy imaging [abstract]. J Nucl Med 2002;43(Suppl):275
  20. Brust P, Haubner R, Friedrich A, Scheunemann M, Anton M, Koufaki ON, Hauses M, Noll S, Noll B, Haberkorn U, Schackert G, Schackert HK, Avril N, Johannsen B. Comparison of $[^{18}F]$FHPG and $[^{124}/^{125}I]$FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression. Eur J Nucl Med 2001;28:721-729 https://doi.org/10.1007/s002590100526
  21. Min JJ, Iyer M, Gambhir SS. Comparison of $[^{18}F]FHBG and [^{14}C]$FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection. Eur J Nucl Med 2003;30:1547-1560 https://doi.org/10.1007/s00259-003-1238-6